PCG
AZN icon

Private Capital Group’s AstraZeneca AZN Stock Holding History

Private Capital Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$258K Sell
1,952
-645
-25% -$84.6K 0.19% 97
2022
Q1 		$345K Sell
2,597
-92
-3% -$11K 0.08% 153
2021
Q4 		$313K Sell
2,689
-567
-17% -$66.7K 0.07% 175
2021
Q3 		$391K Buy
3,256
+971
+42% +$113K 0.09% 143
2021
Q2 		$274K Buy
2,285
+7
+0.3% +$768 0.06% 179
2021
Q1 		$227K Sell
2,278
-1,193
-34% -$120K 0.06% 195
2020
Q4 		$347K Buy
3,471
+243
+8% +$25.7K 0.06% 208
2020
Q3 		$354K Sell
3,228
-225
-7% -$25K 0.07% 180
2020
Q2 		$365K Buy
3,453
+361
+12% +$37.3K 0.08% 173
2020
Q1 		$276K Buy
3,092
+255
+9% +$24K 0.07% 186
2019
Q4 		$282K Buy
2,837
+272
+11% +$25.6K 0.06% 204
2019
Q3 		$229K Sell
2,565
-143
-5% -$12.4K 0.04% 262
2019
Q2 		$190K Buy
2,708
+447
+20% +$35K 0.04% 231
2019
Q1 		$183K Sell
2,261
-92
-4% -$7.25K 0.03% 302
2018
Q4 		$179K Sell
2,353
-630
-21% -$49.2K 0.04% 249
2018
Q3 		$236K Sell
2,983
-231
-7% -$17.5K 0.05% 223
2018
Q2 		$225K Sell
3,214
-1,065
-25% -$76.6K 0.05% 225
2018
Q1 		$299K Sell
4,279
-1,110
-21% -$76.9K 0.07% 183
2017
Q4 		$374 Buy
+5,389
New +$363K 0.09% 149

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Private Capital Group's AZN Position: Q2 2022 in Review

Private Capital Group reduced its AstraZeneca (AZN) stake by 25% in Q2 2022, selling an estimated $84.6K and leaving 1,952 shares worth $258K. The position accounts for 0.19% of the portfolio, ranked #97.

Private Capital Group first reported a position in AZN in Q4 2017 and has held it in 19 quarters since. The position peaked at $391K in Q3 2021. 1,016 funds tracked by Wall St. Rank hold AZN as of Q2 2022.

  • Private Capital Group held 1,952 shares of AstraZeneca worth $258K as of Q2 2022.
  • Private Capital Group sold 645 AstraZeneca shares in Q2 2022, an estimated $84.6K.
  • AstraZeneca made up 0.19% of Private Capital Group's portfolio in Q2 2022, its #97 holding.
  • Private Capital Group first reported a position in AstraZeneca in Q4 2017 and has held it in 19 quarters since.
  • Private Capital Group's AstraZeneca position peaked at $391K in Q3 2021.
  • 1,016 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.